Published in Bioorg Med Chem Lett on January 04, 2006
Characterisation of the cell line HC-AFW1 derived from a pediatric hepatocellular carcinoma. PLoS One (2012) 0.85
Lanthanide-Connecting and Lone-Electron-Pair Active Trigonal-Pyramidal-AsO3 Inducing Nanosized Poly(polyoxotungstate) Aggregates and Their Anticancer Activities. Sci Rep (2016) 0.75
Single-step synthesis of a new series of meso di-Mannich bases from the cyclic aminal (2S,7R,11S,16R)-1,8,10,17-tetraazapentacyclo[8.8.1.1.(8,17)0.(2,7)0(11,16)]icosane and p-substituted phenols. Chem Cent J (2013) 0.75
Platinum-based anticancer agents: innovative design strategies and biological perspectives. Med Res Rev (2003) 1.17
Towards guest-zeolite interactions: an NMR spectroscopic approach. Chemistry (2002) 0.90
Recurrent genomic aberrations in gastric carcinomas associated with Helicobacter pylori and Epstein-Barr virus. Diagn Mol Pathol (2002) 0.85
Overexpression of HMGA1 deregulates tumor growth via cdc25A and alters migration/invasion through a cdc25A-independent pathway in medulloblastoma. Acta Neuropathol (2012) 0.83
An investigation of the roles of surface aluminum and acid sites in the zeolite MCM-22. Chemistry (2002) 0.79
Pharmacokinetics and tissue distribution of novel traditional Chinese medicine-platinum anticancer agents in rats. J Inorg Biochem (2007) 0.79
DNA damage induced by novel demethylcantharidin-integrated platinum anticancer complexes. Biochem Biophys Res Commun (2007) 0.78
In vitro and in vivo suppression of growth of hepatocellular carcinoma cells by novel traditional Chinese medicine-platinum anti-cancer agents. Anticancer Drugs (2005) 0.78
Impact of oxaliplatin and a novel DACH-platinum complex in the gene expression of HCT116 colon cancer cells. Oncol Rep (2008) 0.77
Differential nephrotoxicity of cisplatin and a novel series of traditional Chinese medicine-platinum anticancer agents correlates with their chemical reactivity towards sulfur-containing nucleophiles. Anticancer Drugs (2006) 0.77
Protein phosphatase 2A inhibition and circumvention of cisplatin cross-resistance by novel TCM-platinum anticancer agents containing demethylcantharidin. Bioorg Med Chem (2004) 0.76
East-west fusion-necrosis and apoptosis acting in concert by demethylcantharidin-integrated platinum complexes. Anticancer Agents Med Chem (2014) 0.75
Synergistic interaction between platinum-based antitumor agents and demethylcantharidin. Cancer Lett (2004) 0.75
Determination of the release of hydrolyzed demethylcantharidin from novel traditional chinese medicine-platinum compounds with anticancer activity by gas chromatography. J Chromatogr A (2002) 0.75